Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 137, pseudogene (RNU6-137P) is a **pseudogene** form of U6 small nuclear RNA (snRNA)[1][5]. U6 snRNA is a core structural and catalytic RNA component of the major spliceosome, the ribonucleoprotein complex responsible for **pre-mRNA splicing** in eukaryotic cells[3][6]. However, pseudogenes like RNU6-137P are typically non-functional genomic sequences that resemble true genes but lack the ability to encode a functional product due to sequence disruptions or regulatory defects[1][5]. There is no evidence that RNU6-137P is biologically functional, involved in disease processes, or serves as a drug target. **Key clarification:** - RNU6-137P is a genomic pseudogene, not a protein, enzyme, active RNA, or receptor[1][5]. - It is not a therapeutic target, not biologically active, and not relevant for drug development or biomarker applications. - Its annotation stems from its sequence similarity to active U6 snRNA genes, but pseudogenes such as this are not generally attributed active molecular or disease functions. If you intend to study the functional U6 snRNA or key spliceosome components, this would not be the correct genetic entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 137, pseudogene (RNU6-137P).